Lowery Frederick M.

Lowery Frederick M., an Executive Vice President, has engaged in a mix of buying and selling activity across three companies—Thermo Fisher Scientific (TMO), DuPont (DD), and Henry Schein (HSIC)—with a clear net selling bias. According to SEC Form 4 filings, his 31 transactions total $7.52 million in buys and $19.78 million in sales, reflecting a nearly 3:1 ratio favoring disposals. The bulk of his selling occurred in December 2025, when he offloaded $8.16 million worth of TMO shares across two transactions, supplemented by derivative dispositions totaling $3.51 million. In contrast, his purchases have been smaller and more sporadic, including multiple sub-$100,000 acquisitions of TMO stock through derivative transactions, such as a $271,861 purchase on February 28, 2026, and routine $38,750 awards in DD stock. Recent activity shows a continuation of this trend, with no buys recorded since early 2026 and two sales—both involving HSIC, though with no disclosed dollar value. Lowery’s trading pattern suggests a focus on TMO, where the majority of his high-value sales and derivative-related acquisitions have taken place. While his DD holdings appear to be primarily award-driven, his TMO transactions reflect a more active management of his equity position, with notable disposals in late 2025 followed by smaller derivative-based purchases in early 2026. The absence of recent buying activity, coupled with the liquidation of HSIC positions, indicates a potential shift toward reducing exposure, though the lack of disclosed values for the HSIC sales limits further insight.